Store
Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 11th Edition (2025 to 2030)
Publication Date: March 13, 2026
Tags: COVID-19, Diagnostic Instruments, Influenza, Molecular Diagnostics, Molecular Point-of-Care, Point-of-Care (POC) Testing, Respiratory Diseases
Pages: 145
SKU: 26-018KA
Molecular point-of-care testing continues to reshape diagnostic workflows by bringing the accuracy of molecular methods closer to the patient. In Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 11th Edition (2025 to 2030), Kalorama Information examines a market that has matured significantly over the past decade while remaining dynamic. Distinctions between true point-of-care and near patient molecular testing are not always clear, but Kalorama defines the core value of mPOC as smaller, portable diagnostic devices that answer workflows with rapid turnaround times that make molecular testing practical in physician offices and other decentralized settings.
What This Report Covers
This report provides a comprehensive assessment of the global molecular point-of-care market, with coverage that includes:
- Market estimates and forecasts for systems and consumables through 2030
- Segmentation by region, disease area, and company
- Analysis of both true molecular point-of-care systems and the broader near patient molecular market
- Market and product level revenue estimates supported by primary and secondary research
Research inputs include company disclosures, government publications, trade journals, business press, analyst reports, legal filings, and interviews with manufacturers, laboratories, and industry experts. All market values are expressed in current U.S. dollars and reflect base year sales for 2025.
How Kalorama Defines Molecular Point-of-Care
The report distinguishes between two primary market segments:
- True molecular point-of-care systems, characterized by small footprints, rapid turnaround times, and CLIA waived status or near term waiver potential
- Near patient molecular systems, which include larger or modular platforms that support moderate or high complexity testing in decentralized settings
Key Applications and Growth Opportunities
Historically, mPOC systems have been most successful in respiratory testing, a trend reinforced by COVID-19. While this segment remains price sensitive and competitive with immunoassays, the report identifies additional growth opportunities.
Recent approvals of rapid PCR and molecular home tests have further expanded the addressable market and reinforced the clinical relevance of mPOC technologies.
Table of Contents
Chapter 1: Executive Summary
About Kalorama Information
Scope and Methodology
mPOC Market Overview
Defining True Molecular Point‑of‑Care
Defining Near‑Patient Molecular POC
Where Is Molecular Point-of-Care in 2026?
True mPOC Systems
- Table 1-1: Global Molecular Point-of-Care Market, 2025-2030 ($ million)
“Near-Patient” Molecular Systems Market
- Table 1-2: Global Near Patient Molecular Systems Market, 2025-2030 ($ million)
mPOC Market Observations and Trends
Usage of Molecular Point-of-Care
Leading mPOC Platforms
- Table 1-3: Molecular POC Diagnostic Platforms and Technologies
Trends
Chapter 2: Molecular Point-of-Care Market Development and Trends
Molecular POC and COVID-19
- Table 2-1: Molecular POC COVID-19 Tests and Regulatory Status
CDC Initial Response, Long Term Situation
COVID-19’s Unique Challenge
BARDA Directs Funding to mPO
Regulatory Developments
Consortia, Funding, Prizes
Deals
- Table 2-2: Deals in Molecular Point-of-Care, April 2019-December 2025
Advantages and Disadvantages of Molecular Point-of-Care
- Table 2-3: Disadvantages of Molecular Point-of-Care, by Setting [Physician Office Laboratory (POL) / Other Outpatient Settings, Developing and Low-Resource Areas, and Hospital POC]
Justification: The Sensitivity/Specificity Argument
New Systems and Menu Expansion
New Systems Introduced, in Development
Combination Tests Changing Market: SARS-CoV-2, Flu A, Flu B, and RSV
STI Continues to Be a Growth Area
Deals, Investment in mPOC Systems
Roche’s Supply and Manufacturing Agreement with Sapphiros
Cepheid’s Partnership with Oxford Nanopore
Roche Acquires LumiraDx
Thermo Acquires Mesa Biotech
China as a POC Market
Common Tests and Analytes in POC Diagnostics
Component Technologies of Molecular Point-of-Care Diagnostics
Microfluidics
Quantitative PCR (qPCR)
Microarrays
Isothermal Amplification
Test Automation
Primers and Probes
Detection
Molecular Diagnostics
Real-Time PCR (qPCR)
Isothermal Amplification Methods
Line Probe Assays
Next-Generation Sequencing
Applications and Potential Applications for Molecular Point-of-Care
Major Testing Areas for Molecular POC Diagnostics
Influenza
Reclassification of RIDTs
Hospital-Acquired Infections (HAIs)
Strep A
Respiratory Syncytial Virus (RSV)
Emerging Applications
Zika
Other Respiratory Infections
Group B Streptococcus
Human Papillomavirus
Herpes Simplex Virus
Vaginitis
Tuberculosis
Malaria
Other Tropical and Neglected Diseases
Cancer
European Device Regulations
Chapter 3: mPOC Market Analysis
Molecular Point-of-Care Market Analysis
- Table 3-1: Global Molecular Point-of-Care Market, 2025-2030 ($ million)
- Figure 3-1: Global Molecular Point-of-Care Market, 2025-2030 ($ million)
Market Assumptions and Conclusions
Regional Shares
- Table 3-2: Geographic Breakout of the Molecular Point-of-Care (mPOC) Market, by Region, 2025 ($ million) [APAC, Europe, North America, Rest of World]
Segment Breakout
- Figure 3-2: Global True mPOC Market, by Disease Indication, 2025 (%) [Respiratory, Other]
“Near Patient Molecular” Market
- Table 3-3: Global Near Patient Molecular Systems Market, 2025-2030 ($ million)
- Figure 3-3: Global Near Patient Molecular Systems Market, 2025-2030 ($ million)
- Figure 3-4: Global Near Patient mPOC Market Share, by Segment, 2025 (%) [Respiratory/COVID, STI/Women’s Health, Other]
- Figure 3-5: Global Respiratory Near Patient mPOC Market Share, by Test Type, 2025 (%) [Combo/Syndromic, Single Pathogen]
Market Share Near Patient
- Figure 3-6: Near Patient Molecular Testing Market Share, by Vendor, 2025 (%)
Chapter 4: Company Profiles
Abbott Laboratories
Aidian Oy
Akonni Biosystems
binx health, inc.
Biocartis NV
bioMérieux SA
- Table 4-1: FilmArray and SpotFire Est. Systems Installed per Quarter, Q4 2018-Q3 2025
- Figure 4-1: FilmArray and SpotFire Est. Systems Installed by Quarter, Q4 2018-Q3 2025
- Figure 4-2: bioMérieux Molecular Biology Revenues by Quarter, Q1 2016-Q3 2025
Cepheid (Danaher)
Molecular Healthcare-Acquired Infection (HAI) Testing
Molecular Sexual Health and Women’s Health Testing
Molecular Critical Infectious Disease Testing
Molecular Oncology/Genetics Testing
Credo Diagnostics Biomedical Pte. Ltd.
Curetis NV (OpGen)
DiaSorin S.p.A
GenMark Diagnostics (Roche)
Greiner Bio-One GmbH
Meridian Bioscience, Inc. (SD Biosensor)
Mesa Biotech, Inc. (Thermo)
Sherlock Biosciences
QIAGEN NV
QuantuMDx Group
QuidelOrtho Corporation
Roche
Sekisui Diagnostics LLC
Related products
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition
April 23, 2024
Explore the latest trends and forecasts in the point-of-care (POC) diagnostic tests market with Kalorama Information’s The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. Discover the key growth areas and technological advancements shaping the future of POC diagnostics.
Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in…
Price range: $7,000.00 through $10,000.00
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
Price range: $5,000.00 through $7,875.00
The World Market for Veterinary Diagnostics, 7th Edition
January 22, 2024
Unlock the potential of the veterinary diagnostics market with Kalorama Information’s comprehensive report, The World Market for Veterinary Diagnostics, 7th Edition, which dives deep into the world of animal healthcare diagnostics. From disease identification to monitoring, veterinarians rely on a variety of tests for accurate diagnoses and effective treatment plans. Our report provides a detailed…
Price range: $5,000.00 through $7,875.00
